SCHEMBL29659348

SCHEMBL29659348

CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 1.00
ESR2 Q92731 6/20 1.00
MAPT P10636 3/20 1.00
MEN1 O00255 3/20 1.00
TP53 P04637 3/20 1.00
CYP3A4 P08684 3/20 1.00
KMT2A Q03164 3/20 1.00
ESRRG P62508 3/20 1.00
PGR P06401 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP2D6 P10635 2/20 1.00
HTR6 P50406 2/20 1.00
NPC1 O15118 1/20 1.00
NR1I2 O75469 1/20 1.00
PRKD3 O94806 1/20 1.00
ABCB11 O95342 1/20 1.00
EGFR P00533 1/20 1.00
GBA1 P04062 1/20 1.00
NR3C1 P04150 1/20 1.00
ERBB2 P04626 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tamoxifen SCHEMBL119181 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL17262082 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL4084 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL1056785 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL4085 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL17262111 1.00 ESR1 (1.00) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL5789295 0.99 ESR1 (0.97) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL3794383 0.99 ESR1 (0.97) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL4323848 0.99 ESR1 (0.97) ESR1ESR2MAPTMEN1TP53
Tamoxifen SCHEMBL4323842 0.99 ESR1 (0.97) ESR1ESR2MAPTMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115038455-A Replication-enhanced oncolytic adenoviruses 曼珍公司 2022-09-09 CN claimed
EP-4680268-A1 REACTIVE INTERMEDIATE DEAMINASE A (RIDA) FOR USE IN PREVENTING AND/OR TREATING CACHEXIA Bussolati, Giovanni (IT) 2026-01-21 EP disclosed
CN-120154912-A Game offline resource loading monitoring method, device, equipment and medium 广州虎牙科技有限公司 2025-06-17 CN disclosed
CN-119047119-A BIM data model version management method based on version identifier 中国交通信息科技集团有限公司 2024-11-29 CN disclosed
US-20240352079-A1 Silk-Based Products, Formulations, and Methods of Use COCOON BIOTECH INC. 2024-10-24 US disclosed
WO-2024189565-A1 REACTIVE INTERMEDIATE DEAMINASE A (RIDA) FOR USE IN PREVENTING AND/OR TREATING CACHEXIA BUSSOLATI GIOVANNI (IT) 2024-09-19 WO disclosed
CN-117851312-B Data reading system, electronic component, electronic device and data reading method 北京象帝先计算技术有限公司 2024-06-21 CN disclosed
CN-117851312-A Data reading system, electronic component, electronic device and data reading method 北京象帝先计算技术有限公司 2024-04-09 CN disclosed
EP-4227768-A1 ROLE DETECTION FOR USB-BASED CHARGING INTEL Corporation (US) 2023-08-16 EP disclosed
US-20230161723-A1 ROLE DETECTION FOR USB-BASED CHARGING INTEL CORPORATION 2023-05-25 US disclosed
EP-4184287-A1 ROLE DETECTION FOR USB-BASED CHARGING INTEL Corporation (US) 2023-05-24 EP disclosed
EP-4010012-A1 FUSION PROTEINS AGAINST SIALOSYLATED GLYCOSPHINGOLIPIDS AND SIALATED GLYCOPROTEINS AND USES THEREOF On. Target Molecules Biotech Inc. (US) 2022-06-15 EP disclosed